Breath Analysis Based Disease Biomarkers

Mayo Clinic46 enrolled

Overview

The purpose of the study is to develop a clinical test based on breath analysis that can be used for disease diagnosis or prognosis.

The study will seek to collect and analyze breath samples from a broad range of patients to develop reference ranges and to refine the testing methods. Protocols for breath sample collection and algorithms for analysis will be developed. Samples will be collected from normal volunteers, persons with documented liver disease, organ transplant or with known COVID-19 test results.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Liver Diseases Liver Cancer COVID19

Interventions

Collection of breath sampleDIAGNOSTIC_TEST

Analysis of volatile organic compounds in breath

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Able to provide informed consent Exclusion Criteria: * None

Locations (1)

Mayo Clinic Florida

Jacksonville, Florida, United States

Outcomes

Primary Outcomes

Breath Volatile Organic Compound Profiles

Detection of profiles of volatile organic compounds present in exhaled breath. The values in the table represent the number of participants from whom a volatile organic compound profile was able to be detected.

Time frame: 1 day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.